Alnylam Pharmaceuticals (ALNY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ALNY | AMGN | GILD | CELG | ILMN |
| Company | Alnylam Pharmaceuticals | Amgen Inc | Gilead Sciences Inc | Celgene Corp | Illumina Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 146.70 | 267.54 | 67.35 | 108.01 | 117.86 |
| High | 147.49 | 268.77 | 67.55 | 108.59 | 120.06 |
| Low | 145.19 | 263.39 | 66.89 | 107.27 | 117.42 |
| Last | 145.32 | 264.07 | 66.93 | 108.24 | 118.29 |
| Change | -1.40 | -1.57 | -0.38 | +0.11 | +0.60 |
| % Change | -0.95% | -0.59% | -0.56% | +0.10% | +0.51% |
| Volume | 601,200 | 2,175,100 | 5,287,700 | 191,230,496 | 1,866,300 |
| 20-Day Average Volume | 538,660 | 2,225,995 | 6,258,365 | 16,188,930 | 1,501,215 |
| Previous Close | 146.72 | 265.64 | 67.31 | 108.13 | 117.69 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | No | Yes |
| Technicals | |||||
| 20-Day Moving Average | 150.70 | 273.48 | 70.61 | 108.17 | 130.21 |
| 20-Day Raw Stochastic | 10.59% | 2.72% | 0.54% | 63.25% | 5.34% |
| 20-Day Relative Strength | 38.98% | 37.63% | 29.70% | 64.69% | 36.66% |
| Weighted Alpha | -31.81 | +4.99 | -24.05 | +46.30 | -44.94 |
| Today's Opinion | 100% Sell | 56% Sell | 100% Sell | 100% Buy | 72% Sell |
| Previous Opinion | 100% Sell | 40% Sell | 100% Sell | 100% Buy | 72% Sell |
| Last Month's Opinion | 100% Sell | 8% Sell | 88% Sell | 100% Buy | 40% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | -4.65% since 04/10/24 | -0.89% since 04/10/24 | -1.75% since 04/10/24 | -1.97% since 11/13/19 | -9.82% since 04/10/24 |
| Low | 145.19 on 04/17/24 | 263.39 on 04/17/24 | 66.89 on 04/17/24 | 107.27 on 11/20/19 | 116.83 on 04/16/24 |
| High | 154.02 on 04/11/24 | 273.00 on 04/11/24 | 69.03 on 04/11/24 | 110.53 on 11/14/19 | 134.85 on 04/12/24 |
| 1-Month | |||||
| %Chg | -2.65% since 03/15/24 | -1.79% since 03/15/24 | -9.17% since 03/15/24 | +5.14% since 10/18/19 | -7.39% since 03/15/24 |
| Low | 143.66 on 03/22/24 | 263.39 on 04/17/24 | 66.89 on 04/17/24 | 102.40 on 10/21/19 | 116.83 on 04/16/24 |
| High | 159.34 on 04/09/24 | 288.57 on 03/28/24 | 74.28 on 03/21/24 | 110.70 on 11/13/19 | 144.19 on 03/21/24 |
| 3-Month | |||||
| %Chg | -22.93% since 01/17/24 | -13.16% since 01/17/24 | -22.61% since 01/17/24 | +13.63% since 08/20/19 | -11.43% since 01/17/24 |
| Low | 143.52 on 02/15/24 | 263.39 on 04/17/24 | 66.89 on 04/17/24 | 93.41 on 08/23/19 | 116.83 on 04/16/24 |
| High | 191.72 on 01/24/24 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 110.70 on 11/13/19 | 148.19 on 01/31/24 |
| 6-Month | |||||
| %Chg | -12.45% since 10/17/23 | -7.15% since 10/17/23 | -16.84% since 10/17/23 | +14.14% since 05/20/19 | -10.30% since 10/17/23 |
| Low | 143.52 on 02/15/24 | 249.70 on 10/31/23 | 66.89 on 04/17/24 | 89.08 on 07/23/19 | 89.00 on 11/10/23 |
| High | 199.38 on 01/09/24 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 110.70 on 11/13/19 | 148.19 on 01/31/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 18,478,796 | 142,361,536 | 83,806,128 | 77,035,920 | 18,742,722 |
| Shares Outstanding, K | 125,946 | 535,919 | 1,245,077 | 711,714 | 159,255 |
| Annual Sales | 1,828,290,000 | 28,190,000,000 | 27,116,000,000 | 15,281,000,000 | 4,504,000,000 |
| Annual Net Income | -440,240,000 | 6,717,000,000 | 5,665,000,000 | 4,046,000,000 | -1,161,000,000 |
| Last Quarter Sales | 439,720,000 | 8,196,000,000 | 7,114,000,000 | 4,520,000,000 | 1,122,000,000 |
| Last Quarter Net Income | -137,870,000 | 767,000,000 | 1,429,000,000 | 1,691,000,000 | -176,000,000 |
| 60-Month Beta | 0.39 | 0.58 | 0.19 | 1.41 | 1.19 |
| Per-Share Information | |||||
| Most Recent Earnings | -1.10 on 02/15/24 | 4.71 on 02/06/24 | 1.72 on 02/06/24 | 2.99 on 10/31/19 | 0.14 on 02/08/24 |
| Latest Earnings Date | 05/02/24 | 05/02/24 | 04/25/24 | 10/31/19 | 05/02/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 05/16/24 | 03/14/24 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.24 | 10.08 | 10.99 | 139.26 |